Other Income & Expense

Gain on Sale of Business

This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026May 5, 2026

How to read this metric

A gain indicates successful divestiture of non-core assets, while a loss may suggest impairment or forced liquidation.

Detailed definition

This represents the net profit or loss realized from the divestiture of a business unit, subsidiary, or significant asse...

Peer comparison

Commonly reported by large conglomerates and financial services firms undergoing strategic portfolio shifts.

Metric ID: etn_gain_on_sale_of_business

Historical Data

2 periods
 Q1 '25Q1 '26
Value$0.00$28.60M
Range$0.00 – $28.60M

Gain on Sale of Business at Other Companies

Lennox International logo
Lennox InternationalLIIView metric
Tyson Foods logo
Tyson FoodsTSNView metric
Global Payments logo
Global PaymentsGPNView metric
Constellation Brands logo
Constellation BrandsSTZView metric
STERIS logo
STERISSTEView metric
Regions Financial logo
Regions FinancialRFView metric

Frequently Asked Questions

What is Neurocrine Biosciences's gain on sale of business?
Neurocrine Biosciences (NBIX) reported gain on sale of business of $28.60M in Q1 2026.
What does gain on sale of business mean?
The profit or loss recognized from selling a business unit or subsidiary.